Yang Xu Selected Research

Hepatocellular Carcinoma (Hepatoma)

4/2023	Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI.
3/2023	Tubeimoside-2 Triggers Methuosis in Hepatocarcinoma Cells through the MKK4-p38α Axis.
2/2023	Synergistic anticancer effect of flavonoids from Sophora alopecuroides with Sorafenib against hepatocellular carcinoma.
5/2022	MicroRNA214 expression inhibits HCC cell proliferation through PTK2b/ Pyk2.
1/2022	IFNα Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment.
12/2021	The mRNA-miRNA-lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma.
5/2021	TSG101 Promotes the Proliferation, Migration, and Invasion of Human Glioma Cells by Regulating the AKT/GSK3β/β-Catenin and RhoC/Cofilin Pathways.
1/2021	The PGC1α/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib/doxorubicin treatment in hepatocellular carcinoma.
1/2021	Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma.
1/2021	Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yang Xu Research Topics

Disease

319	Neoplasms (Cancer) 05/2024 - 01/2002
65	Inflammation (Inflammations) 04/2024 - 09/2006
62	Hepatocellular Carcinoma (Hepatoma) 04/2023 - 07/2004
61	Infections 04/2024 - 01/2005
56	Neoplasm Metastasis (Metastasis) 02/2024 - 07/2004
32	Carcinogenesis 11/2023 - 01/2005
29	Glioma (Gliomas) 04/2024 - 01/2017
26	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 03/2013
23	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2011
23	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2023 - 07/2002
20	Pain (Aches) 04/2024 - 03/2010
19	Obesity 05/2024 - 11/2013
19	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 12/2011
19	Atherosclerosis 11/2022 - 08/2003
18	Lung Neoplasms (Lung Cancer) 03/2024 - 06/2004
18	Esophageal Squamous Cell Carcinoma 11/2023 - 02/2013
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 08/2003
16	Hypoxia (Hypoxemia) 02/2024 - 01/2014
15	Barth Syndrome 01/2023 - 06/2005
14	Body Weight (Weight, Body) 04/2024 - 05/2013
14	Leukemia 03/2024 - 07/2002
14	Wounds and Injuries (Trauma) 02/2024 - 08/2014
13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 10/2013
13	Liver Neoplasms (Liver Cancer) 12/2020 - 03/2012
12	Necrosis 02/2024 - 01/2014
12	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 05/2012
12	Multiple Myeloma 01/2023 - 09/2010
12	Spinal Cord Injuries (Spinal Cord Injury) 12/2022 - 01/2014
11	Hematologic Neoplasms (Hematological Malignancy) 05/2024 - 12/2012
11	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2017
11	COVID-19 03/2024 - 10/2020
11	Erythema 03/2024 - 01/2013
11	Stroke (Strokes) 01/2024 - 01/2013
11	Fibrosis (Cirrhosis) 11/2023 - 01/2015
11	Residual Neoplasm 08/2023 - 01/2018
11	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2005
10	Hypertension (High Blood Pressure) 10/2023 - 01/2017
10	Genomic Instability 10/2023 - 06/2013
10	Rosacea (Acne Rosacea) 01/2023 - 08/2019
9	Brain Ischemia (Cerebral Ischemia) 02/2024 - 01/2013
9	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 01/2007
9	Hyperglycemia 12/2023 - 02/2014
9	Non-alcoholic Fatty Liver Disease 09/2023 - 06/2015
9	Virus Diseases (Viral Diseases) 01/2023 - 10/2009
9	Lymphoma (Lymphomas) 01/2023 - 04/2016
9	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2013
8	Insulin Resistance 05/2024 - 01/2014
8	Adenocarcinoma 04/2024 - 08/2013
8	Heart Failure 03/2024 - 11/2014
8	Disease Progression 02/2024 - 08/2004
8	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 04/2008

Drug/Important Bio-Agent (IBA)

111	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2004
62	Biomarkers (Surrogate Marker)IBA 02/2024 - 08/2004
38	Messenger RNA (mRNA)IBA 04/2024 - 12/2005
38	CytokinesIBA 12/2023 - 06/2004
30	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2002
25	MicroRNAs (MicroRNA)IBA 02/2024 - 03/2012
25	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 11/2013
24	Phosphotransferases (Kinase)IBA 12/2023 - 01/2005
21	Long Noncoding RNAIBA 02/2024 - 01/2016
20	Therapeutic UsesIBA 05/2024 - 03/2005
19	AntigensIBA 08/2023 - 02/2011
18	AntioxidantsIBA 02/2024 - 09/2011
18	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2009
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024 - 12/2005
16	Antiviral Agents (Antivirals)IBA 10/2023 - 06/2007
15	Peptides (Polypeptides)IBA 04/2024 - 03/2007
15	LipidsIBA 01/2023 - 10/2011
14	Interleukin-6 (Interleukin 6)IBA 04/2024 - 06/2004
14	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2019
14	LigandsIBA 01/2023 - 01/2006
13	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 08/2013
13	EnzymesIBA 06/2022 - 01/2005
13	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2009
12	IronIBA 11/2023 - 07/2012
12	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2010
11	Tyrosine Kinase InhibitorsIBA 02/2024 - 01/2010
10	AcidsIBA 11/2023 - 01/2016
10	Apolipoproteins E (ApoE)IBA 11/2023 - 12/2006
10	Indicators and Reagents (Reagents)IBA 10/2023 - 06/2007
10	Protein Kinases (Protein Kinase)IBA 08/2023 - 04/2006
10	Amino Acids FDA Link 01/2023 - 01/2008
10	Cardiolipins (Cardiolipin)IBA 01/2023 - 08/2006
10	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 04/2004
9	VaccinesIBA 03/2024 - 10/2004
9	CholesterolIBA 11/2023 - 08/2003
9	Oxygen (Dioxygen)IBA 08/2023 - 11/2014
9	Carbon Nanotubes (Carbon Nanotube)IBA 01/2019 - 03/2009
8	CateninsIBA 10/2023 - 01/2016
8	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 01/2011

Therapy/Procedure

152	Therapeutics 05/2024 - 06/2004
39	Hematopoietic Stem Cell Transplantation 04/2024 - 02/2002
31	Immunotherapy 04/2024 - 10/2013
31	Drug Therapy (Chemotherapy) 02/2024 - 08/2003
20	Transplantation 02/2024 - 03/2004
19	Radiotherapy 02/2024 - 07/2007
15	Aftercare (After-Treatment) 04/2024 - 08/2008
10	Stem Cell Transplantation 02/2024 - 02/2002
9	Length of Stay 01/2023 - 09/2017
8	Lasers (Laser) 01/2023 - 03/2009